BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 30413412)

  • 1. Treatment-Induced Tumor Cell Apoptosis and Secondary Necrosis Drive Tumor Progression in the Residual Tumor Microenvironment through MerTK and IDO1.
    Werfel TA; Elion DL; Rahman B; Hicks DJ; Sanchez V; Gonzales-Ericsson PI; Nixon MJ; James JL; Balko JM; Scherle PA; Koblish HK; Cook RS
    Cancer Res; 2019 Jan; 79(1):171-182. PubMed ID: 30413412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the Immune Response to Tumor Cell Apoptosis and Efferocytosis.
    Werfel TA
    Methods Mol Biol; 2022; 2543():45-55. PubMed ID: 36087258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution.
    Stanford JC; Young C; Hicks D; Owens P; Williams A; Vaught DB; Morrison MM; Lim J; Williams M; Brantley-Sieders DM; Balko JM; Tonetti D; Earp HS; Cook RS
    J Clin Invest; 2014 Nov; 124(11):4737-52. PubMed ID: 25250573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer.
    Li F; Zhao Y; Wei L; Li S; Liu J
    Cancer Biol Ther; 2018 Aug; 19(8):695-705. PubMed ID: 29621426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction.
    Wan E; Yeap XY; Dehn S; Terry R; Novak M; Zhang S; Iwata S; Han X; Homma S; Drosatos K; Lomasney J; Engman DM; Miller SD; Vaughan DE; Morrow JP; Kishore R; Thorp EB
    Circ Res; 2013 Sep; 113(8):1004-12. PubMed ID: 23836795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indoleamine 2,3-dioxygenase regulates anti-tumor immunity in lung cancer by metabolic reprogramming of immune cells in the tumor microenvironment.
    Schafer CC; Wang Y; Hough KP; Sawant A; Grant SC; Thannickal VJ; Zmijewski J; Ponnazhagan S; Deshane JS
    Oncotarget; 2016 Nov; 7(46):75407-75424. PubMed ID: 27705910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of the Phagocytic Receptor MerTK on Tumor-Associated Macrophages Enhances P2X7R-Dependent STING Activation by Tumor-Derived cGAMP.
    Zhou Y; Fei M; Zhang G; Liang WC; Lin W; Wu Y; Piskol R; Ridgway J; McNamara E; Huang H; Zhang J; Oh J; Patel JM; Jakubiak D; Lau J; Blackwood B; Bravo DD; Shi Y; Wang J; Hu HM; Lee WP; Jesudason R; Sangaraju D; Modrusan Z; Anderson KR; Warming S; Roose-Girma M; Yan M
    Immunity; 2020 Feb; 52(2):357-373.e9. PubMed ID: 32049051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-dependent kinase activity of MERTK drives efferocytosis in human iPSC-derived macrophages.
    Wanke F; Gutbier S; Rümmelin A; Steinberg M; Hughes LD; Koenen M; Komuczki J; Regan-Komito D; Wagage S; Hesselmann J; Thoma R; Brugger D; Christopeit T; Wang H; Point F; Hallet R; Ghosh S; Rothlin CV; Patsch C; Geering B
    Cell Death Dis; 2021 May; 12(6):538. PubMed ID: 34035216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial cell-directed efferocytosis in the post-partum mammary gland is necessary for tissue homeostasis and future lactation.
    Sandahl M; Hunter DM; Strunk KE; Earp HS; Cook RS
    BMC Dev Biol; 2010 Dec; 10():122. PubMed ID: 21192804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MERTK tyrosine kinase receptor together with TIM4 phosphatidylserine receptor mediates distinct signal transduction pathways for efferocytosis and cell proliferation.
    Nishi C; Yanagihashi Y; Segawa K; Nagata S
    J Biol Chem; 2019 May; 294(18):7221-7230. PubMed ID: 30846565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice.
    Thorp E; Cui D; Schrijvers DM; Kuriakose G; Tabas I
    Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1421-8. PubMed ID: 18451332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efferocytosis in the tumor microenvironment.
    Werfel TA; Cook RS
    Semin Immunopathol; 2018 Nov; 40(6):545-554. PubMed ID: 30187085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IDO1 Inhibition Overcomes Radiation-Induced "Rebound Immune Suppression" by Reducing Numbers of IDO1-Expressing Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.
    Li A; Barsoumian HB; Schoenhals JE; Caetano MS; Wang X; Menon H; Valdecanas DR; Niknam S; Younes AI; Cortez MA; Welsh JW
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):903-912. PubMed ID: 30905636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory T Cells Promote Macrophage Efferocytosis during Inflammation Resolution.
    Proto JD; Doran AC; Gusarova G; Yurdagul A; Sozen E; Subramanian M; Islam MN; Rymond CC; Du J; Hook J; Kuriakose G; Bhattacharya J; Tabas I
    Immunity; 2018 Oct; 49(4):666-677.e6. PubMed ID: 30291029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efferocytosis is restricted by axon guidance molecule EphA4 via ERK/Stat6/MERTK signaling following brain injury.
    Soliman E; Leonard J; Basso EKG; Gershenson I; Ju J; Mills J; de Jager C; Kaloss AM; Elhassanny M; Pereira D; Chen M; Wang X; Theus MH
    J Neuroinflammation; 2023 Nov; 20(1):256. PubMed ID: 37941008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganoderic acid Me induces the apoptosis of competent T cells and increases the proportion of Treg cells through enhancing the expression and activation of indoleamine 2,3-dioxygenase in mouse lewis lung cancer cells.
    Que Z; Zou F; Zhang A; Zheng Y; Bi L; Zhong J; Tian J; Liu J
    Int Immunopharmacol; 2014 Nov; 23(1):192-204. PubMed ID: 25138378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoproteasome subunit β5i regulates diet-induced atherosclerosis through altering MERTK-mediated efferocytosis in Apoe knockout mice.
    Liao J; Xie Y; Lin Q; Yang X; An X; Xia Y; Du J; Wang F; Li HH
    J Pathol; 2020 Mar; 250(3):275-287. PubMed ID: 31758542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the Regulatory T-Cell/Indoleamine 2,3-Dioxygenase Axis Reduces Vascular Inflammation and Atherosclerosis in Hyperlipidemic Mice.
    Forteza MJ; Polyzos KA; Baumgartner R; Suur BE; Mussbacher M; Johansson DK; Hermansson A; Hansson GK; Ketelhuth DFJ
    Front Immunol; 2018; 9():950. PubMed ID: 29867939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
    Yu J; Du W; Yan F; Wang Y; Li H; Cao S; Yu W; Shen C; Liu J; Ren X
    J Immunol; 2013 Apr; 190(7):3783-97. PubMed ID: 23440412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological and nonimmunological effects of indoleamine 2,3-dioxygenase on breast tumor growth and spontaneous metastasis formation.
    Levina V; Su Y; Gorelik E
    Clin Dev Immunol; 2012; 2012():173029. PubMed ID: 22654951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.